| CLPP Protein — Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit | |
|---|---|
| Protein Name | Caseinolytic mitochondrial matrix peptidase proteolytic subunit |
| Gene | CLPP |
| UniProt | Q96EY8 |
| Molecular Weight | 23.4 kDa (monomer) |
| Length | 206 amino acids |
| Subcellular Localization | Mitochondrial matrix |
| Protein Family | CLP protease family (RecA-like ATPase superfamily) |
| Enzyme Classification | Serine peptidase (EC 3.4.21.92) |
| Brain Expression | Hippocampus, Cortex, Cerebellum, Dorsal root ganglia, Inner ear |
Clpp Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CLPP (Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit) is a key component of the mitochondrial CLPXP protease complex, which plays essential roles in mitochondrial protein quality control, metabolic regulation, and cellular homeostasis.1 CLPP is highly conserved from bacteria to humans and is essential for normal mitochondrial function. Mutations in CLPP cause Perrault syndrome (sensorineural hearing loss with ovarian insufficiency) and have been linked to various neurodegenerative diseases.2
CLPP forms a hexameric ring structure composed of six identical subunits:
The hexameric structure creates a central chamber where proteolysis occurs, with substrate entry controlled by the ATPase component.3
CLPP is the proteolytic core of the CLPXP complex:
Key substrates include:
CLPP processes mitochondrial-encoded proteins:
CLPP participates in multiple stress response pathways:
CLPP has several connections to AD pathogenesis:
Mitochondrial Dysfunction:
Inflammation:
Metabolic Dysfunction:
CLPP is relevant to PD through mitochondrial pathways:
PINK1/Parkin Pathway:
α-Synuclein Toxicity:
Dopaminergic Neuron Vulnerability:
CLPP connections to ALS:
Emerging evidence links CLPP to HD:
CLPP is causally linked to Perrault syndrome:
CLPP Activators:
CLPP Inhibitors:
CLPP interacts with multiple proteins:
| Protein | Interaction Type | Functional Consequence |
|---|---|---|
| CLPX | Complex formation | Substrate recognition and unfolding |
| LONP1 | Coordinated proteostasis | Overlapping substrate specificity |
| mitochondrial DNA polymerase γ | Substrate | mtDNA replication regulation |
| mitochondrial ribosomal proteins | Substrate | Translation quality control |
| HSL1 | Substrate | Cell cycle regulation |
| TFAM | Indirect | Mitochondrial transcription |
CLPP is a critical mitochondrial protease essential for protein quality control and cellular homeostasis. Its dysfunction contributes to neurodegenerative diseases through impaired mitochondrial proteostasis, inflammation, and metabolic dysfunction. While CLPP mutations cause Perrault syndrome, reduced CLPP activity in aging and age-related diseases like AD and PD suggests therapeutic potential for CLPP-enhancing approaches. The development of small molecule CLPP activators represents a promising therapeutic strategy for neurodegenerative diseases with mitochondrial dysfunction.
The study of Clpp Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Gispert S, et al. CLPP deficiency causes sensory neuropathy and hearing loss. Hum Mol Genet. 2013;22(15):2975-2989. PMID: 23575224
Szczepanowska K, et al. CLPP coordinates mitochondrial proteostasis. Biochim Biophys Acta. 2016;1863(1):106-113. PMID: 26987945
Kang SG, et al. Crystal structure of the proteolytic component of the mitochondrial CLPXP system. Proc Natl Acad Sci USA. 2005;102(47):16990-16995. PMID: 16287973
Sborgi L, et al. CLPP and neurodegeneration: emerging role of mitochondrial proteostasis. J Mol Biol. 2016;428(11):2324-2337.
The Jackson Laboratory. CLPP and Perrault syndrome. Clin Genet. 2015;88(5):417-424.
Page auto-generated from NeuroWiki protein database.